Abstract
Hereditary hemochromatosis (HHC) is a disorder of iron metabolism and has been classified into six types having similar phenotypes but caused by mutations in different genes involved in the regulation of iron stores. Two allelic variants of the HFE gene, p.C282Y (c.845G>A) and p.H63D (c.187C>G), are significantly correlated with HHC, and most clinical studies have focused on these variants. Diagnosis of HHC is based on clinical, biochemical, histological, and molecular studies, specifically tests such as transferrin saturation, ferritin concentration, evaluation of iron stores by liver biopsy, and genotyping for p.C282Y and p.H63D mutations in HFE. Hemoglobinopathies are the most common single-gene diseases in the world. Approximately 5–7 % of the world’s population is a carrier for one of the hemoglobin disorders. Two copies of the alpha (α) globin genes are present (α1 and α2) on each chromosome 16. The beta and beta-like chains (ε, Gγ, Aγ, and δ) are clustered on chromosome 11. The hemoglobinopathies are commonly divided into two broad categories: structural variants, and thalassemias that are characterized by reduced rates of production of α or β chains. Sickle hemoglobin results from a single nucleotide substitution (GAG→GTG) that changes codon 6 of the β-globin gene from a glutamic acid to a valine (Glu6Val). Homozygosity for this mutation causes sickle cell disease (SD), an autosomal recessive disorder. SD is a major cause of morbidity and mortality in Africa and in populations with individuals of African descent. The α-thalassemias are most commonly caused by deletions while the β-thalassemias are most likely due to single nucleotide substitutions or frameshift mutations. Single nucleotide changes causing either structural variants or thalassemias can be easily diagnosed by targeted mutation analysis or by sequencing. Gap-PCR or multiplex ligation dependent probe amplification assays are the common methods to detect deletions. The Rh antigen system is clinically important because antibodies to Rh antigens are involved in hemolytic transfusion reactions, autoimmune hemolytic anemia, and hemolytic disease of the fetus and newborn. The Rh antigens are expressed on proteins encoded by two distinct but highly homologous genes, RHD and RHCE, on chromosome 1p34.3-36.1. The D antigen is expressed from RHD and the C/c and E/e antigens are expressed from RHCE. Rh incompatibility cases require both phenotypic and genotypic testing of parental samples.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Imperatore G, Pinsky LE, Motulsky A, Reyes M, Bradley LA, Burke W. Hereditary hemochromatosis: perspectives of public health, medical genetics, and primary care. Genet Med. 2003;5:1–8.
Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol. 2001;154:193–206.
Weiss G. Genetic mechanisms and modifying factors in hereditary hemochromatosis. Nat Rev Gastroenterol Hepatol. 2010;7:50–8.
Kowdley KV, Bennet RL, Motulsky A. HFE-associated hereditary hemochromatosis. GeneReviews [serial online] 2012. Accessed 19 Apr, 12 A.D.
Zhou XY, Tomatsu S, Fleming RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1998;95:2492–7.
Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408.
Burke W, Imperatore G, McDonnell SM, Baron RC, Khoury MJ. Contribution of different HFE genotypes to iron overload disease: a pooled analysis. Genet Med. 2000;2:271–7.
Allen KJ, Gurrin LC, Constantine CC, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358:221–30.
Somerville MJ, Sprysak KA, Hicks M, Elyas BG, Vicen-Wyhony L. An HFE intronic variant promotes misdiagnosis of hereditary hemochromatosis. Am J Hum Genet. 1999;65:924–6.
Beutler E, Gelbart T. A common intron 3 mutation (IVS3-48c→g) leads to misdiagnosis of the c.845G→A (C282Y) HFE gene mutation. Blood Cells Mol Dis. 2000;26:229–33.
Pointon JJ, Merryweather-Clarke AT, Carella M, Robson KJ. Detection of C282Y and H63D in the HFE gene. Genet Test. 2000;4:115–20.
Lyon E, Frank EL. Hereditary hemochromatosis since discovery of the HFE gene. Clin Chem. 2001;47:1147–56.
Weatherall DJ. The thalassemias: disorders of globin synthesis. In: Kaushansky K, Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Prchal JT, editors. Williams hematology. 8th ed. New York: McGraw-Hill; 2010. p. 675–707.
Higgs DR. Alpha thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, editors. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. 2nd ed. New York: Cambridge University Press; 2009. p. 241–323.
Cao A, Galanello R. Beta-thalassemia. GeneReviews [serial online] 2010.
Hatcher SL, Trang QT, Robb KM, Teplitz RL, Carlson JR. Prenatal diagnosis by enzymatic amplification and restriction endonuclease digestion for detection of haemoglobins A, S and C. Mol Cell Probes. 1992;6:343–8.
Hermann MG. Genotyping b-globin mutations (HbS, HbC, HbE) by muliplexing probe color and melting temperature. In: Meuer S, Wittwer CT, Nakagawara K, editors. Rapid cycle real-time PCR: methods and applications. Heidelberg: Springer; 2001. p. 119–25.
Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alpha-thalassemia. Blood. 2001;98:250–1.
Tuzmen S, Schechter AN. Genetic diseases of hemoglobin: diagnostic methods for elucidating beta-thalassemia mutations. Blood Rev. 2001;15:19–29.
Moreno I, Bolufer P, Perez ML, Barragan E, Sanz MA. Rapid detection of the major Mediterranean beta-thalassaemia mutations by real-time polymerase chain reaction using fluorophore-labelled hybridization probes. Br J Haematol. 2002;119:554–7.
Bowman JM. Immune hemolytic disease. In: Nathan DG, Oski FA, editors. Hematology of infancy and childhood. 5th ed. Philadelphia: W.B. Saunders; 1998. p. 53–78.
Avent ND, Reid ME. The Rh blood group system: a review. Blood. 2000;95:375–87.
Wagner FF, Flegel WA. RHCE represents the ancestral RH position, while RHD is the duplicated gene. Blood. 2002;99:2272–3.
Reid ME, Lomas-Francis C. The blood group antigen facts book. 2nd ed. London: Academic; 2004.
Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood. 2000;95:12–8.
van der Schoot CE, Tax GH, Rijnders RJ, De Haas M, Christiaens GC. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev. 2003;17:31–44.
Moise Jr KJ. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol. 2008;112:164–76.
Oepkes D, Seaward PG, Vandenbussche FP, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med. 2006;355:156–64.
Reid ME, Rios M, Powell VI, Charles-Pierre D, Malavade V. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion. 2000;40:48–53.
Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet. 2001;2:10.
Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion. 2002;42:1079–85.
Denomme GA, Johnson ST, Pietz BC. Mass-scale red cell genotyping of blood donors. Transfus Apher Sci. 2011;44:93–9.
Pirelli KJ, Pietz BC, Johnson ST, Pinder HL, Bellissimo DB. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D. Prenat Diagn. 2010;30:1207–12.
Bombard AT, Akolekar R, Farkas DH, et al. Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat Diagn. 2011;31:802–8.
Tynan JA, Angkachatchai V, Ehrich M, Paladino T, van den Boom D, Oeth P. Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing. Am J Obstet Gynecol. 2011;204:251–6.
Nygren AO, Dean J, Jensen TJ, et al. Quantification of fetal DNA by use of methylation-based DNA discrimination. Clin Chem. 2010;56:1627–35.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bellissimo, D.B., Agarwal, A. (2016). Hematologic Disorders: Hemochromatosis, Hemoglobinopathies, and Rh Incompatibility. In: Leonard, D. (eds) Molecular Pathology in Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-19674-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-19674-9_16
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19673-2
Online ISBN: 978-3-319-19674-9
eBook Packages: MedicineMedicine (R0)